UNH Shorts Sit on Losses as Recovery Extends to 11%

UnitedHealth Group enters the back half of October with a sharper question than the one that defined earnings week: the short position built into the Q3 print is still there, the stock has continued to climb, and the fundamental debate around Stars ratings and Optum margins has not resolved.

The stock gained 11% over the past week to close at $419.26, extending the post-earnings recovery that began on October 13. That day's 4.5% surge on the Q3 beat has compounded into a move that now puts the pre-earnings short position, opened near $380, roughly 10% underwater. The market cap is back above $365 billion. Options positioning reflects the shift: the put/call ratio has dropped to 0.80, nearly 1.75 standard deviations below its 20-day average of 0.83. That is the least defensive options setup UNH has seen in months, and it tracks directly against the mid-September peak of 0.94 when the stock was under pressure. Borrow availability remains essentially unconstrained, with almost no portion of the lending pool in use. The short position at 15.95 million shares is a choice to hold, not a forced stay.

That position has not moved. Short interest has been flat at 15.95 million shares since October 9, sitting at 1.76% of the free float. As previously reported, this is the same block that jumped 20.7% in a single session before the print. The cost to borrow has edged higher, up roughly 7% on the week to 0.42%, and is now 36% above its level a month ago. That creep in borrowing cost against a static position is worth watching: it can signal either new shorts paying more to enter, or existing holders being rolled at higher rates. With availability so loose, the former is the more likely read. Either way, the shorts are paying more to maintain a position that keeps moving against them.

The Street's reaction to Q3 has been broadly constructive, though not uniformly so. JP Morgan's Lisa Gill raised her target to $524 from $516 within days of the print, keeping an Overweight rating. RBC Capital lifted its target to $498 on October 20, the most recent move in the dataset. Piper Sandler pushed to $504. Bernstein trimmed slightly to $500 but held Outperform. The consensus mean now stands at $478, implying roughly 14% upside from current levels. The lone dissenter in the recent activity is TD Cowen, which holds a $402 target and a Hold rating, sitting below the current price. Baird also carries a Neutral with a $427 target, modestly above the close. The bull case rests on Optum's diversified earnings base, the guidance lift to at least $20.50 in adjusted EPS for 2026 (implying more than 25% growth year on year), and high-90s membership retention. The bear case centres on Stars ratings deterioration, with 68% of members now in four-plus-star contracts compared with 80% in 2027, a structural headwind the company has acknowledged. The EV/EBITDA multiple at 13.4x and PE at 18.4x have both expanded over the past 30 days as the stock recovered, though neither is extreme by the stock's own history.

Institutional ownership shows a cluster of adds rather than trims at the last reported quarter end. BlackRock increased its position by 3.4 million shares to 76.9 million, maintaining its 8.6% stake as the largest disclosed holder. FMR added 14.5 million shares, the largest absolute increase in the top-15, bringing its position to 22.8 million shares. Capital Research and JP Morgan Asset Management both added modestly. One notable development in the activist register: The Vanguard Group filed a Schedule 13G/A in March 2026 showing its stake had dropped from 10.08% to zero, while a separate Vanguard Capital Management entity filed a 13G in April carrying 7.5% of the class. These are as-last-disclosed around the 5% threshold, and holders falling below 5% may exit without a further filing, so the Vanguard structure warrants no more than a noting.

Wikipedia attention has climbed to a z-score of roughly 2.0 against the stock's own 90-day history, the highest retail attention reading in the period tracked. That spike maps directly onto the Q3 earnings period and the subsequent price recovery. It is attention, not a revenue signal, but it does confirm that UNH has drawn a wider audience over the past two weeks than it typically does.

What to watch: whether the 15.95 million share short position begins to show any movement as the stock presses further above the level where it was established, and whether the cost to borrow continues its quiet drift higher as the recovery extends toward the low-$400s analyst targets.